The EU policy towards this substance has been established on the grounds of persisting scientific uncertainty about the safety of products derived from animals treated with ractopamine and opposition to the use of veterinary drugs as growth promoters.
Seda ainet käsitlev ELi poliitika on kehtestatud raktopamiini saanud loomadest saadud toodete ohutuse suhtes jätkuva teadusliku ebakindluse alusel ning vastuseisu alusel kasutada veterinaarravimeid kasvustimulaatoritena.